Concepts (193)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Image Interpretation, Computer-Assisted | 13 | 2020 | 3356 | 1.320 |
Why?
|
| Brain | 23 | 2024 | 27101 | 1.120 |
Why?
|
| Magnetic Resonance Imaging | 27 | 2024 | 36402 | 1.090 |
Why?
|
| Image Processing, Computer-Assisted | 11 | 2022 | 8998 | 0.940 |
Why?
|
| Pattern Recognition, Automated | 9 | 2017 | 994 | 0.920 |
Why?
|
| Algorithms | 20 | 2022 | 14018 | 0.790 |
Why?
|
| Subtraction Technique | 6 | 2014 | 512 | 0.770 |
Why?
|
| Uniparental Disomy | 1 | 2021 | 45 | 0.740 |
Why?
|
| Intelligence | 1 | 2024 | 923 | 0.660 |
Why?
|
| Nasopharyngeal Neoplasms | 1 | 2020 | 290 | 0.590 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 1 | 2020 | 389 | 0.550 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 4 | 2018 | 2789 | 0.540 |
Why?
|
| Hypoxia-Ischemia, Brain | 1 | 2019 | 352 | 0.520 |
Why?
|
| Breast Feeding | 2 | 2022 | 1354 | 0.500 |
Why?
|
| Child Development | 3 | 2023 | 2300 | 0.470 |
Why?
|
| Imaging, Three-Dimensional | 8 | 2019 | 4058 | 0.470 |
Why?
|
| Myelin Sheath | 3 | 2024 | 653 | 0.450 |
Why?
|
| Longevity | 1 | 2021 | 1064 | 0.430 |
Why?
|
| Brain Mapping | 6 | 2022 | 6634 | 0.410 |
Why?
|
| Infant, Newborn | 13 | 2022 | 26180 | 0.380 |
Why?
|
| Infant | 17 | 2023 | 36152 | 0.370 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2021 | 1394 | 0.360 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2020 | 1390 | 0.360 |
Why?
|
| Image Enhancement | 8 | 2014 | 2881 | 0.350 |
Why?
|
| Dyslexia | 2 | 2022 | 208 | 0.340 |
Why?
|
| Databases, Factual | 5 | 2020 | 7960 | 0.340 |
Why?
|
| Ultrasonography | 2 | 2019 | 5964 | 0.330 |
Why?
|
| Sturge-Weber Syndrome | 2 | 2022 | 89 | 0.320 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2014 | 637 | 0.310 |
Why?
|
| Atlases as Topic | 4 | 2020 | 247 | 0.300 |
Why?
|
| Health Services Research | 1 | 2014 | 1808 | 0.270 |
Why?
|
| Brain Neoplasms | 6 | 2019 | 9026 | 0.270 |
Why?
|
| Artificial Intelligence | 4 | 2012 | 2574 | 0.250 |
Why?
|
| Brain Injuries | 1 | 2017 | 2053 | 0.240 |
Why?
|
| Lutein | 2 | 2022 | 123 | 0.240 |
Why?
|
| Preoperative Care | 1 | 2014 | 2241 | 0.240 |
Why?
|
| Child, Preschool | 9 | 2022 | 42188 | 0.240 |
Why?
|
| Autistic Disorder | 2 | 2024 | 1219 | 0.240 |
Why?
|
| Child | 15 | 2024 | 80079 | 0.230 |
Why?
|
| Biopsy, Needle | 1 | 2009 | 1624 | 0.230 |
Why?
|
| Magnetic Resonance Imaging, Cine | 3 | 2017 | 1048 | 0.220 |
Why?
|
| Intelligence Tests | 1 | 2024 | 503 | 0.220 |
Why?
|
| Humans | 56 | 2024 | 760617 | 0.200 |
Why?
|
| Surgery, Computer-Assisted | 2 | 2019 | 1002 | 0.190 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2021 | 15908 | 0.190 |
Why?
|
| Mathematical Concepts | 1 | 2020 | 73 | 0.180 |
Why?
|
| Cytogenetic Analysis | 1 | 2021 | 270 | 0.170 |
Why?
|
| Young Adult | 8 | 2024 | 59179 | 0.170 |
Why?
|
| Reading | 2 | 2022 | 531 | 0.170 |
Why?
|
| Lactation | 1 | 2021 | 397 | 0.160 |
Why?
|
| Seizures | 3 | 2022 | 2954 | 0.160 |
Why?
|
| Adult | 16 | 2024 | 220969 | 0.160 |
Why?
|
| Carotenoids | 1 | 2021 | 621 | 0.160 |
Why?
|
| Mothers | 3 | 2023 | 2194 | 0.150 |
Why?
|
| Reproducibility of Results | 11 | 2015 | 20074 | 0.150 |
Why?
|
| Diffusion Tensor Imaging | 2 | 2020 | 2400 | 0.150 |
Why?
|
| Ischemic Attack, Transient | 1 | 2024 | 874 | 0.150 |
Why?
|
| Alzheimer Disease | 4 | 2024 | 8601 | 0.150 |
Why?
|
| Signal Processing, Computer-Assisted | 3 | 2021 | 1493 | 0.150 |
Why?
|
| Software | 3 | 2021 | 4431 | 0.150 |
Why?
|
| Sensitivity and Specificity | 9 | 2014 | 14648 | 0.140 |
Why?
|
| Adolescent | 7 | 2024 | 88234 | 0.130 |
Why?
|
| Prostatic Neoplasms | 4 | 2017 | 11106 | 0.130 |
Why?
|
| Anatomy, Artistic | 1 | 2015 | 51 | 0.130 |
Why?
|
| Adrenoleukodystrophy | 1 | 2017 | 143 | 0.130 |
Why?
|
| Female | 25 | 2024 | 392148 | 0.130 |
Why?
|
| Anti-Bacterial Agents | 1 | 2014 | 7402 | 0.120 |
Why?
|
| Hydrocortisone | 1 | 2023 | 1819 | 0.120 |
Why?
|
| Organ Size | 1 | 2020 | 2252 | 0.120 |
Why?
|
| Middle Aged | 12 | 2024 | 220584 | 0.120 |
Why?
|
| Probability | 1 | 2019 | 2475 | 0.110 |
Why?
|
| Child Abuse | 1 | 2023 | 1076 | 0.110 |
Why?
|
| International Classification of Diseases | 1 | 2019 | 909 | 0.110 |
Why?
|
| Skull | 1 | 2018 | 818 | 0.110 |
Why?
|
| Male | 24 | 2024 | 360358 | 0.110 |
Why?
|
| Solitary Pulmonary Nodule | 1 | 2017 | 278 | 0.110 |
Why?
|
| Neoplasms | 1 | 2022 | 22131 | 0.110 |
Why?
|
| Phenylurea Compounds | 1 | 2016 | 529 | 0.110 |
Why?
|
| Nutritional Status | 1 | 2021 | 1596 | 0.110 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 1 | 2016 | 664 | 0.110 |
Why?
|
| Microcirculation | 1 | 2017 | 1272 | 0.100 |
Why?
|
| Aged | 9 | 2024 | 169042 | 0.100 |
Why?
|
| Glioblastoma | 2 | 2018 | 3481 | 0.100 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2017 | 709 | 0.100 |
Why?
|
| Aged, 80 and over | 4 | 2022 | 58894 | 0.100 |
Why?
|
| Prospective Studies | 7 | 2024 | 54360 | 0.090 |
Why?
|
| Quinolines | 1 | 2016 | 764 | 0.090 |
Why?
|
| Gadolinium DTPA | 1 | 2014 | 823 | 0.090 |
Why?
|
| Taxoids | 1 | 2014 | 667 | 0.090 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2021 | 3769 | 0.090 |
Why?
|
| Tetralogy of Fallot | 2 | 2017 | 618 | 0.090 |
Why?
|
| Attention | 1 | 2021 | 2396 | 0.090 |
Why?
|
| Fractures, Bone | 1 | 2022 | 2044 | 0.090 |
Why?
|
| Cohort Studies | 4 | 2022 | 41457 | 0.080 |
Why?
|
| Prostate | 1 | 2017 | 1773 | 0.080 |
Why?
|
| Cyclophosphamide | 1 | 2014 | 2218 | 0.080 |
Why?
|
| Computational Biology | 1 | 2020 | 3509 | 0.080 |
Why?
|
| Neurosurgical Procedures | 1 | 2019 | 2067 | 0.080 |
Why?
|
| Prognosis | 4 | 2024 | 29600 | 0.080 |
Why?
|
| Apolipoproteins E | 1 | 2013 | 1443 | 0.070 |
Why?
|
| China | 1 | 2014 | 2374 | 0.070 |
Why?
|
| Doxorubicin | 1 | 2014 | 2224 | 0.070 |
Why?
|
| Breast Neoplasms | 1 | 2014 | 20988 | 0.070 |
Why?
|
| Multiple Myeloma | 1 | 2024 | 5146 | 0.070 |
Why?
|
| Heart Ventricles | 2 | 2017 | 3796 | 0.070 |
Why?
|
| Tumor Microenvironment | 1 | 2018 | 3868 | 0.060 |
Why?
|
| Contrast Media | 2 | 2018 | 5305 | 0.060 |
Why?
|
| Atrophy | 2 | 2024 | 1631 | 0.060 |
Why?
|
| Reference Standards | 2 | 2021 | 1002 | 0.060 |
Why?
|
| Age Factors | 1 | 2020 | 18381 | 0.060 |
Why?
|
| Clinical Trials as Topic | 1 | 2019 | 7995 | 0.060 |
Why?
|
| Diet | 1 | 2021 | 8048 | 0.060 |
Why?
|
| Guideline Adherence | 1 | 2014 | 2218 | 0.060 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2014 | 2118 | 0.060 |
Why?
|
| Population | 2 | 2014 | 141 | 0.050 |
Why?
|
| Neoadjuvant Therapy | 1 | 2014 | 2827 | 0.050 |
Why?
|
| Consultants | 1 | 2022 | 56 | 0.050 |
Why?
|
| Follow-Up Studies | 2 | 2021 | 39063 | 0.050 |
Why?
|
| Treatment Outcome | 3 | 2019 | 64568 | 0.050 |
Why?
|
| Photometry | 1 | 2021 | 57 | 0.050 |
Why?
|
| Lung Neoplasms | 2 | 2024 | 13382 | 0.050 |
Why?
|
| Pregnancy | 2 | 2022 | 29868 | 0.050 |
Why?
|
| alpha-Tocopherol | 1 | 2022 | 126 | 0.050 |
Why?
|
| Maternal Behavior | 1 | 2023 | 307 | 0.050 |
Why?
|
| Area Under Curve | 2 | 2017 | 1635 | 0.050 |
Why?
|
| Hippocampus | 2 | 2023 | 3761 | 0.040 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2016 | 9277 | 0.040 |
Why?
|
| Clavicle | 1 | 2022 | 224 | 0.040 |
Why?
|
| Retrospective Studies | 5 | 2024 | 80566 | 0.040 |
Why?
|
| Electronic Health Records | 1 | 2017 | 4803 | 0.040 |
Why?
|
| Immunophenotyping | 1 | 2024 | 1865 | 0.040 |
Why?
|
| Longitudinal Studies | 3 | 2024 | 14591 | 0.040 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2024 | 11736 | 0.040 |
Why?
|
| Cross-Sectional Studies | 2 | 2018 | 26049 | 0.040 |
Why?
|
| Motor Skills | 1 | 2022 | 521 | 0.040 |
Why?
|
| tau Proteins | 2 | 2024 | 2094 | 0.040 |
Why?
|
| Lung | 1 | 2017 | 9998 | 0.040 |
Why?
|
| Language Development | 1 | 2020 | 183 | 0.040 |
Why?
|
| Artifacts | 2 | 2020 | 1910 | 0.040 |
Why?
|
| Hemizygote | 1 | 2017 | 28 | 0.040 |
Why?
|
| Radiography | 2 | 2022 | 6961 | 0.040 |
Why?
|
| Milk, Human | 1 | 2021 | 486 | 0.040 |
Why?
|
| Social Behavior | 1 | 2023 | 1135 | 0.030 |
Why?
|
| Bipolar Disorder | 1 | 2014 | 5091 | 0.030 |
Why?
|
| Corpus Callosum | 1 | 2021 | 751 | 0.030 |
Why?
|
| Amyloid beta-Peptides | 2 | 2024 | 3839 | 0.030 |
Why?
|
| Depressive Disorder, Major | 1 | 2014 | 4764 | 0.030 |
Why?
|
| Biopsy | 1 | 2007 | 6762 | 0.030 |
Why?
|
| Permeability | 1 | 2017 | 721 | 0.030 |
Why?
|
| Cerebral Cortex | 2 | 2023 | 5776 | 0.030 |
Why?
|
| Amygdala | 1 | 2023 | 1353 | 0.030 |
Why?
|
| ROC Curve | 2 | 2013 | 3575 | 0.030 |
Why?
|
| Killer Cells, Natural | 1 | 2024 | 2191 | 0.030 |
Why?
|
| Antineoplastic Agents, Alkylating | 1 | 2018 | 617 | 0.030 |
Why?
|
| Water | 1 | 2021 | 1409 | 0.030 |
Why?
|
| Asymptomatic Diseases | 1 | 2017 | 587 | 0.030 |
Why?
|
| Metabolome | 1 | 2021 | 987 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2017 | 20556 | 0.030 |
Why?
|
| Schizophrenia | 1 | 2012 | 6929 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2016 | 13635 | 0.030 |
Why?
|
| Dendritic Cells | 1 | 2024 | 2722 | 0.030 |
Why?
|
| Psychiatric Status Rating Scales | 2 | 2013 | 6016 | 0.030 |
Why?
|
| Blood-Brain Barrier | 1 | 2017 | 1027 | 0.020 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2017 | 1431 | 0.020 |
Why?
|
| False Positive Reactions | 1 | 2012 | 957 | 0.020 |
Why?
|
| Diagnostic Imaging | 1 | 2024 | 3527 | 0.020 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2018 | 3514 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2022 | 17878 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2022 | 8618 | 0.020 |
Why?
|
| Ultrasonography, Interventional | 1 | 2017 | 1496 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2016 | 4010 | 0.020 |
Why?
|
| Cerebrovascular Circulation | 1 | 2017 | 2726 | 0.020 |
Why?
|
| Neovascularization, Pathologic | 1 | 2016 | 2644 | 0.020 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 1 | 2012 | 1988 | 0.020 |
Why?
|
| Schizophrenic Psychology | 1 | 2012 | 1646 | 0.020 |
Why?
|
| Survival Rate | 1 | 2018 | 12719 | 0.010 |
Why?
|
| Glioma | 1 | 2019 | 3453 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2016 | 10073 | 0.010 |
Why?
|
| Gadolinium | 1 | 2008 | 959 | 0.010 |
Why?
|
| Logistic Models | 1 | 2017 | 13245 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2017 | 12966 | 0.010 |
Why?
|
| Mice | 1 | 2009 | 81368 | 0.010 |
Why?
|
| Aging | 1 | 2020 | 8699 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 2013 | 5110 | 0.010 |
Why?
|
| Neuropsychological Tests | 1 | 2013 | 7050 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2017 | 22148 | 0.010 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2017 | 5672 | 0.010 |
Why?
|
| Antipsychotic Agents | 1 | 2012 | 3066 | 0.010 |
Why?
|
| Genotype | 1 | 2013 | 12978 | 0.010 |
Why?
|
| Animals | 1 | 2009 | 168201 | 0.010 |
Why?
|
| Disease Progression | 1 | 2013 | 13495 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2012 | 15251 | 0.010 |
Why?
|
| Mutation | 1 | 2017 | 30016 | 0.010 |
Why?
|
Concepts
(193)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(68)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_